Parenkumar Patel
Internal Medicine · Wesley Chapel, FLNPI 1760613012
Payments from drug & device makers
Across 295 payments — averaging $806.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$231K
- Eli Lilly Export S.A. Puerto Rico Branch$2K
- AstraZeneca$1K
- GSK$930
- Novo Nordisk$910
- Boehringer Ingelheim$373
- plus $2K from 28 others
Across 1 payment — averaging $29,402 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$29K
What the payments were for
- Food & beverage$5,416100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 3 | $231,106 |
| Eli Lilly Export S.A. Puerto Rico Branch | 2 | $1,519 |
| AstraZeneca | 73 | $1,289 |
| GSK | 49 | $930 |
| Novo Nordisk | 57 | $910 |
| Boehringer Ingelheim | 21 | $373 |
| Pfizer | 15 | $330 |
| Lilly USA, LLC | 13 | $278 |
| Bayer | 6 | $172 |
| Shield Therapeutics Inc | 8 | $154 |
| Johnson & Johnson | 7 | $139 |
| AbbVie | 5 | $106 |
| Myriad Women's Health, Inc. | 1 | $67 |
| Nevro Corp. | 3 | $59 |
| Currax Pharmaceuticals LLC | 4 | $58 |
| Hologic Sales And Service, LLC | 2 | $50 |
| Corcept Therapeutics | 2 | $46 |
| Amarin Pharma, Inc. | 2 | $43 |
| Lucid Diagnostics Inc. | 2 | $40 |
| Sanofi-aventis U.S. LLC | 2 | $36 |
| Phadia US Inc. | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| Amgen | 2 | $32 |
| Dexcom, Inc. | 1 | $32 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| Itamar Medical Inc | 1 | $28 |
| Renalytix AI, Inc. | 1 | $25 |
| Upsher-smith Laboratories LLC | 1 | $21 |
| Recor Medical Inc | 1 | $19 |
| Astellas Pharma US Inc | 1 | $19 |
| Abbott | 1 | $18 |
| Biogen | 1 | $15 |
| Exact Sciences | 1 | $15 |
| Gilead | 1 | $15 |
How this compares
$238,041 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 32 | $41,142 |
| FarxigaDapagliflozin Propanediol | 44 | $38,835 |
| EliquisApixaban | 29 | $34,749 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $22,163 |
| XareltoRivaroxaban | 19 | $16,669 |
| Tresiba Flextouch U-200Insulin Degludec | 16 | $11,939 |
| MounjaroTirzepatide | 11 | $11,204 |
| Glipizide ErGlipizide | 400 | $6,885 |
| Losartan Potassium | 958 | $6,260 |
| Atorvastatin Calcium | 922 | $5,451 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 16 | $5,402 |
| Levothyroxine Sodium | 586 | $5,339 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 16 | $4,993 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 34 | $3,663 |
| Midodrine Hcl | 14 | $3,358 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $373 | $41,14232 claims |
| AstraZenecaFarxiga | $1,289 | $38,83544 claims |
| PfizerEliquis | $330 | $34,74929 claims |
| GSKTrelegy Ellipta | $930 | $22,16315 claims |
| Johnson & JohnsonXarelto | $139 | $16,66919 claims |
| Lilly USA, LLCMounjaro | $278 | $11,20411 claims |
| Sanofi-aventis U.S. LLCLantus | $36 | $1,73115 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,530 internal medicine providers in Florida.
Other internal medicine in Wesley Chapel
- Yaneicy Gonzalez RojasCoral Gables$93.5M
- Juan Carlos RondonHollywood$66.8M
- Jaynier MoyaPembroke Pines$45.4M
- Mark KutnerMiami$35.7M
- Gilberto JimenezHialeah$35.6M
- Mira BaronWest Palm Beach$29.6M
- William SanchezHialeah$28.9M
- Nelia Sanchez-CrespoHollywood$28.8M
- Kwabena AyesuOrlando$27.6M
- Michael DeverWindermere$24M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.